Rapid skin improvement with upadacitinib with or without topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

被引：0
|
作者：
Simpson, Eric L. [1 ]
Warren, Richard B. [2 ]
Eichenfield, Lawrence F. [3 ,4 ]
Katoh, Norito [5 ]
Hu, Xiaofei [6 ]
Zeng, Jiewei [6 ]
Calimlim, Brian M. [6 ]
Tenorio, Allan R. [6 ]
Teixeira, Henrique D. [6 ]
De Bruin-Weller, Marjolein [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA
[2] Univ Manchester, Salford Royal NHS Fdn Trust, Manchester NIHR Biomed Res Ctr, Dermatol Ctr, Manchester, Lancs, England
[3] Univ Calif San Diego, Sch Med, Dept Dermatol, San Diego, CA USA
[4] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA USA
[5] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto, Japan
[6] AbbVie Inc, N Chicago, IL USA
[7] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
27915
引用
收藏
页码：AB167 / AB167
页数：1
相关论文
共 50 条
  • [1] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Blauvelt, Andrew
    Ardern-Jones, Michael R.
    Bieber, Thomas
    Hong, Chih-Ho
    Chu, Chia-Yu
    Liu, Meng
    Yang, Yang
    Ladizinski, Barry
    Teixeira, Henrique D.
    Calimlim, Brian M.
    Thyssen, Jacob P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB171 - AB171
  • [2] RAPID SYMPTOM AND SLEEP IMPROVEMENT WITH UPADACITINIB WITH OR WITHOUT TOPICAL CORTICOSTEROIDS (TCS) IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM 3 PHASE 3 STUDIES (MEASURE UP 1, MEASURE UP 2, AND AD UP)
    Ardern-Jones, Michael R.
    Beck, Lisa A.
    Calimlim, Brian M.
    Zeng, Jiewei
    Chu, Alvina D.
    Prajapati, Vimal H.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 34 - 35
  • [3] RAPID QUALITY-OF-LIFE IMPROVEMENT WITH UPADACITINIB WITH OR WITHOUT TOPICAL CORTICOSTEROIDS (TCS) IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM 3 PHASE 3 STUDIES (MEASURE UP 1, MEASURE UP 2, AND AD UP)
    Eyerich, Kilian
    Lynde, Charles W.
    Calimlim, Brian M.
    Liu, Meng
    Ladizinski, Barry
    Warren, Richard B.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 34 - 34
  • [4] Rapid skin improvement with upadacitinib with or without topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Simpson, E. L.
    Warren, R. B.
    Eichenfield, L. F.
    Katoh, N.
    Hu, X.
    Zeng, J.
    Calimlim, B. M.
    Tenorio, A. R.
    Teixeira, H. D.
    De Bruin-Weller, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E118 - E119
  • [5] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Blauvelt, A.
    Ardern-Jones, M. R.
    Bieber, T.
    Hong, C.
    Chu, C. -Y.
    Liu, M.
    Yang, Y.
    Ladizinski, B.
    Teixeira, H. D.
    Calimlim, B. M.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E117 - E118
  • [6] Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Guttman-Yassky, Emma
    Irvine, Alan D.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Waterhouse, Brian
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB129 - AB129
  • [7] Upadacitinib in moderate-to-severe atopic dermatitis: combined safety analysis of phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Guttman-Yassky, Emma
    Irvine, A. D.
    Silverberg, J. I.
    Papp, K. A.
    Paller, A. S.
    Waterhouse, B.
    Tenorio, A. R.
    Ladizinski, B.
    Chu, A. D.
    Liu, J.
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E124
  • [8] Upadacitinib with or without topical corticosteroids improves health-related quality of life in adolescent and adult patients with moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Prajapati, Vimal H.
    Rosmarin, David
    Shumack, Stephen
    Calimlim, Brian M.
    Takemoto, Shunya
    Hu, Xiaofei
    Ladizinski, Barry
    Warren, Richard B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E81 - E81
  • [9] Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase 3 clinical trials at 52 weeks
    Paller, Amy S.
    Mendes-Bastos, Pedro
    Eichenfield, Lawrence F.
    Soong, Weily
    Lio, Peter
    Prajapati, Vimal H.
    Platt, Andrew M.
    Raymundo, Eliza
    Liu, John
    Ladizinski, Barry
    Thyssen, Jacob P.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [10] Efficacy and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Measure Up 1, Measure Up 2, and AD Up Phase 3 Clinical Trials at 52 Weeks
    Paller, Amy
    Mendes-Bastos, Pedro
    Eichenfield, Lawrence
    Soong, Weily
    Lio, Peter
    Prajapati, Vimal
    Platt, Andrew
    Liu, John
    Ladizinski, Barry
    Thyssen, Jacob
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB157 - AB157
12345